Search clinical trials for: 18mg CY150112

Total 1028 results

Acorda Therapeutics
Prometrika, LLC; BCS Consulting, Inc.

Completed

An Open Label, Proof of Concept Study to Evaluate the Effects of Dalfampridine Withdrawal on Gait and Balance Parameters in Subjects With Multiple Sclerosis (MS)

Multiple Sclerosis

United States
Mayo Clinic

Completed

Efficacy of Long-acting Octreotide (Sandostatin LAR) in Reducing Portal Pressure in Patients With Cirrhosis

Cirrhosis | Portal Hypertension | Esophageal Varices
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Ramipril 10 mg Capsules Under Fed Conditions

Healthy

India
Aristotle University Of Thessaloniki

Recruiting

Empagliflozin and Red Blood Cell 2,3-biphosphoglycerate Levels

Cardiovascular Prevention | Tissue Oxygenation | Empagliflozin | SGLT2-Inhibitors | Hematocrit Change

Greece
AstraZeneca

Completed

The Safety and Efficacy of Dapagliflozin Therapy in Combination With Insulin in Japanese Subjects With T1DM

Type 1 Diabetes Mellitus

Japan
GlaxoSmithKline

Completed

Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy In Subjects With Mild To Moderate Alzheimer's Disease (REFLECT-3)

Alzheimer's Disease

United States, Australia, Spain, Bulgaria, Poland, Germany, Philippines, Singapore, Belgium, Canada, Hong Kong, Korea, Republic of, Finland, Slovenia, Czechia, France, South Africa, Sweden, Netherlands, Malaysia, United Kingdom, S...
Affiliated Cancer Hospital & Institute of Guangzhou...

Unknown

Clinical Pharmacokinetics of TKIs in Chinese Patients of Hepatitis B (HBV)

Hepatitis B | Non Small Cell Lung Cancer

China
Peking Union Medical College Hospital

Unknown

Tranexamic Acid in Reducing Gross Hemorrhage and Transfusions of Spine Surgeries (TARGETS)

Intervertebral Disc Displacement | Spinal Stenosis
Instituto Mexicano del Seguro Social
Germán Ramón Bautista López; Luis Jonathan González; Rodolfo Guardado Mendoza; Gabriel...

Completed

Dapagliflozin Effects on Mayor Adverse Cardiovascular Events in Patients With Acute Myocardial Infarction (DAPA-AMI) (DAPA-AMI)

Heart Failure | Angina, Unstable | Acute Myocardial Infarction | Cardiovascular Morbidity

Mexico
Deraya University
Minia University

Completed

Antifungal Potential of Moringa Olifera Against Otomycosis

Otomycosis

Egypt
Chong Kun Dang Pharmaceutical

Completed

The Study to Evaluate Efficacy and Safety of Newrabell® Tab.(Rabeprazole Sodium) 10mg b.i.d in Refractory GERD

Reflux Esophagitis

Korea, Republic of
Hospital Authority, Hong Kong

Completed

Effect of Vardenafil on Blood Pressure in Patients With Erectile Dysfunction Who Received Concomitant Doxazosin GITS

Prostatic Hyperplasia | Impotence

China
NewAmsterdam Pharma

Completed

Randomized Study of Obicetrapib in Combination With Ezetimibe (OCEAN)

Dyslipidemias | Hypercholesterolemia | High Cholesterol

United States, Netherlands
Ain Shams University

Completed

Evaluation of the Effect of SGLT-2 Inhibitors on Cardiac Remodeling in Post Myocardial Infarction Patients

Myocardial Infarction | Diabetes Mellitus, Type 2 | Myocardial Remodeling, Ventricular

Egypt
Ain Shams University

Completed

Clinical Value of Adding Dapagliflozin in Patients With Nephrotic Syndrome

Nephrotic Syndrome | Sodium-Glucose Transporter 2 Inhibitors

Egypt
Postgraduate Medical Institute, Lahore

Completed

Salivary Bmp-2 Levels & Radiographic Measurement Of Bone Density at Extracted Tooth (salivaryBMP2)

Bone Injury

Pakistan
Acorda Therapeutics

Completed

A Study to Evaluate the Efficacy and Safety of Two Dose Strengths of Dalfampridine Extended Release Tablets. (MILESTONE℠)

Post-Ischemic Stroke

United States, Canada
Chengdu Zenitar Biomedical Technology Co., Ltd

Completed

Study of Prilinostat Mesylate for Injection in the Treatment of Relapsed or Refractory B Cell-related Tumor-predominant

Diffuse Large B Cell Lymphoma，DLBCL

China
AstraZeneca

Completed

The PK and PD of Dapagliflozin Therapy in Combination With Insulin in Japanese Subjects With T1DM

Type 1 Diabetes Mellitus

Japan
GlaxoSmithKline

Completed

Acotral® Versus Zetia® Ezetimibe Bioequivalance Study.

Hypercholesterolaemia

India
Shirley Ryan AbilityLab
Rady Children's Hospital, San Diego

Not yet recruiting

Repurposing 5-Azacytidine for the Treatment of Muscle Contractures in Children With Cerebral Palsy

Cerebral Palsy | Contracture
National Taiwan University Hospital

Recruiting

PLT and Steroid in Lateral Epicondylopathy and Supraspinatus Calcific Tendinopathy

Lateral Epicondylitis | Rotator Cuff Syndrome

Taiwan
Sanofi

Completed

Study of Efficacy and Safety of Irbesartan/Amlodipine 4 Fixed Combination Therapy in Hypertensive Patients Uncontrolled on Irbesartan or Amlodipine Monotherapy

Hypertension

Russian Federation
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Glimepiride 1mg Tablets Under Fed Conditions

Healthy

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Glimepiride 1mg Tablets Under Fasting Conditions

Healthy

United States
Yokohama City University
EA Pharma Co., Ltd.

Completed

Efficacy and Safety of Elobixibat in Combination With Cholestyramine for Nonalcoholic Fatty Liver Disease

Nonalcoholic Steatohepatitis | Nonalcoholic Fatty Liver

Japan
Hyo-Soo Kim

Unknown

The Efficacy and Safety of Triple Therapy of Telmisartan/Amlodipine/Rosuvastatin

Hypertension | Dyslipidemias
GlaxoSmithKline

Terminated

Paxil Japanese Post Marketing Paediatric Study in Depression (Double-blind, Placebo Controlled Study)

Depressive Disorder

Japan
Getz Pharma

Not yet recruiting

Effect of Erugliflozin On Liver Fat, Liver Fibrosis and Glycemic Control in Type II DM Patients With NASH/NAFLD (Ertu-NASH)

Body Weight Changes | Liver Fat | Tolerance | Liver Fibrosis | Glycemic Control | Waist Circumference
Hospital Israelita Albert Einstein

Completed

Dapagliflozin in Patients With Critical Illness (DEFENDER)

Sepsis | Critical Illness

Brazil
NewAmsterdam Pharma

Completed

Study to Evaluate the Effect of Obicetrapib in Combination With Ezetimibe as an Adjunct to HIS Therapy (ROSE2)

Dyslipidemias | Hypercholesterolemia | High Cholesterol

United States
University Hospital Schleswig-Holstein

Completed

Lacosamid-i.v.-Register (LCM)

Epilepsy With Partial Onset Seizures With or Without Secondary Generalization

Germany
The Catholic University of Korea
Pfizer

Unknown

Korean AMADEUS Study

Diabetes Mellitus, Hypercholessterolemia

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

CKD-330 Drug-Drug Interaction Study (Candesartan) (CKD-330(C))

Hypertension

Korea, Republic of
Yangjin
Peking University Third Hospital

Not yet recruiting

Evaluation of the Safety and Efficacy of SGLT2 Inhibitors in Pre-diabetic Patients

Prediabetic State | Impaired Glucose Tolerance | Impaired Fasting Glucose

China
Region Örebro County
London School of Hygiene and Tropical Medicine; Odense University Hospital; Göteborg... and other collaborators

Recruiting

SGLT2 Inhibitor TrEatment iN Patients Awaiting cOronary arTery bYpass Surgery to Reduce Post-opErative AF (STENOTYPE)

Atrial Fibrillation | Chronic Coronary Syndrome

Denmark, Sweden, Czechia
Virginia Commonwealth University
National Institute on Drug Abuse (NIDA)

Terminated

Phase I Functional Magnetic Resonance Imaging (fMRI) Pharmacodynamic Studies of Compounds for Opioid Use Disorder and Cocaine Use Disorder

Opioid-Related Disorders | Cocaine-Related Disorders

United States
The University of Hong Kong

Unknown

Effects of Oral Melatonin on Neurosensory Recovery Following Facial Osteotomies

Dentofacial Deformities

Hong Kong
Laval University

Completed

Study of Atorvastatin Dose Dependent Reduction of Proteinuria (SARP)

Chronic Kidney Disease

Canada
Inner Mongolia Yili Industrial Group Co., Ltd

Completed

Study of Yili Lactoferrin ShuHua Milk in the Improvement of Human Immunization

Common Cold | Human Influenza | Immunization

China
Xijing Hospital

Recruiting

Low-dose NOAC Versus GDMT After LAAO (RECORD-III)

Atrial Fibrillation

China
Yungjin Pharm. Co., Ltd.
Seoul National University Hospital

Completed

A Study to Compare the Safety, Pharmacokinetics and Pharmacodynamics of YPI 011 to Rabeprazole in Healthy Adult Subjects

Gastroesophageal Reflux Disease

Korea, Republic of
Ascletis Pharmaceuticals Co., Ltd.

Recruiting

Study to Evaluate Safety, Tolerance and Efficacy of ASC22 Combined With ART in Subjects With HIV

HIV Infections | HIV-1-infection | PD-L1 Gene Mutation

China
Columbia University
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Endothelial Function in Obstructive Sleep Apnea

Obstructive Sleep Apnea of Adult

United States
International AIDS Vaccine Initiative
Beth Israel Deaconess Medical Center, Boston MA; Ragon Institute of MGH, MIT... and other collaborators

Completed

Safety, PK and Antiviral Activity of PGT121 Monoclonal Antibody in HIV-uninfected and HIV-infected Adults

HIV Infection

United States
Oregon Health and Science University
Society of Family Planning

Completed

Opioid Analgesia for MAB

Pain | MAB

United States
Kyunghee University Medical Center
Takeda; Korea University Guro Hospital; Ajou University School of Medicine; Kangbuk... and other collaborators

Unknown

Effect of Alogliptin/Pioglitazone on the Preservation of Long-term Beta-cell Function

Diabetes

Korea, Republic of
Asan Medical Center
Samsung Medical Center; Seoul National University Hospital; Cheil General Hospital... and other collaborators

Completed

Observational Study to Estimate the Dry Mouth in OAB Patients With Solifenacin (OAB)

Overactive Bladder

Korea, Republic of
Huashan Hospital

Recruiting

Optimizing(O) RIfapentine-based(RI) Regimen and shortENing(EN) the Treatment of Drug-sensitive Tuberculosis(T) (ORIENT)

Tuberculosis, Pulmonary

China
The George Institute
University Medical Center Groningen; Australian and New Zealand Intensive Care...

Recruiting

PREVENTion With Sglt-2 Inhibition of Acute Kidney Injury in Intensive Care (PREVENTS-AKI)

Acute Kidney Injury

Australia

Search clinical trials for: 18mg CY150112

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations